Ubs Group Ag Ligand Pharmaceuticals Inc Transaction History

Ubs Group Ag

  • $611 Billion
  • Q3 2025

A detailed history of Ubs Group Ag transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Ubs Group Ag holds 111,986 shares of LGND stock, worth $22.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111,986
Previous 33,510 234.19%
Holding current value
$22.5 Million
Previous $3.81 Million 420.79%
% of portfolio
0.0%
Previous 0.0%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$112.56 - $177.14 $8.83 Million - $13.9 Million
78,476 Added 234.19%
111,986 $19.8 Million
Q2 2025

Aug 14, 2025
BUY
$96.67 - $118.22 $297,163 - $363,408
3,074 Added 10.1%
33,510 $3.81 Million
Q1 2025

May 13, 2025
BUY
$105.14 - $122.23 $350,221 - $407,148
3,331 Added 12.29%
30,436 $3.2 Million
Q4 2024

Feb 14, 2025
BUY
$99.95 - $129.9 $1.56 Million - $2.03 Million
15,608 Added 135.76%
27,105 $2.9 Million
Q3 2024

Nov 14, 2024
SELL
$82.7 - $110.11 $2.26 Million - $3 Million
-27,289 Reduced 70.36%
11,497 $1.15 Million
Q2 2024

Aug 13, 2024
BUY
$68.53 - $87.91 $392,197 - $503,108
5,723 Added 17.31%
38,786 $3.27 Million
Q1 2024

May 13, 2024
BUY
$68.64 - $89.2 $963,431 - $1.25 Million
14,036 Added 73.77%
33,063 $2.42 Million
Q4 2023

Feb 09, 2024
BUY
$49.57 - $72.63 $600,342 - $879,621
12,111 Added 175.12%
19,027 $1.36 Million
Q3 2023

Nov 09, 2023
SELL
$58.86 - $72.67 $68,218 - $84,224
-1,159 Reduced 14.35%
6,916 $414,000
Q2 2023

Aug 11, 2023
BUY
$69.53 - $79.33 $479,339 - $546,901
6,894 Added 583.74%
8,075 $582,000
Q1 2023

May 12, 2023
SELL
$65.67 - $77.08 $31,455 - $36,921
-479 Reduced 28.86%
1,181 $86,000
Q4 2022

Feb 08, 2023
BUY
$61.72 - $96.74 $80,236 - $125,762
1,300 Added 361.11%
1,660 $110,000
Q3 2022

Nov 10, 2022
SELL
$0.01 - $107.56 $3 - $33,343
-310 Reduced 46.27%
360 $31,000
Q2 2022

Aug 10, 2022
SELL
$74.52 - $117.06 $2.28 Million - $3.58 Million
-30,614 Reduced 97.86%
670 $60,000
Q1 2022

May 16, 2022
BUY
$94.99 - $151.56 $419,475 - $669,288
4,416 Added 16.44%
31,284 $3.52 Million
Q4 2021

Feb 14, 2022
SELL
$127.69 - $165.85 $9,449 - $12,272
-74 Reduced 0.27%
26,868 $4.15 Million
Q3 2021

Nov 15, 2021
BUY
$102.33 - $144.73 $1.77 Million - $2.51 Million
17,319 Added 179.98%
26,942 $3.75 Million
Q2 2021

Aug 13, 2021
BUY
$113.03 - $155.64 $663,373 - $913,451
5,869 Added 156.34%
9,623 $1.26 Million
Q1 2021

May 12, 2021
SELL
$99.52 - $215.83 $145,995 - $316,622
-1,467 Reduced 28.1%
3,754 $573,000
Q4 2020

Feb 11, 2021
BUY
$80.55 - $106.05 $31,978 - $42,101
397 Added 8.23%
5,221 $519,000
Q3 2020

Nov 12, 2020
SELL
$89.56 - $126.72 $246,737 - $349,113
-2,755 Reduced 36.35%
4,824 $460,000
Q2 2020

Jul 31, 2020
BUY
$68.28 - $123.65 $221,295 - $400,749
3,241 Added 74.71%
7,579 $848,000
Q1 2020

May 01, 2020
SELL
$63.37 - $107.88 $551,445 - $938,771
-8,702 Reduced 66.73%
4,338 $315,000
Q4 2019

Feb 14, 2020
SELL
$96.94 - $113.59 $3.58 Million - $4.19 Million
-36,912 Reduced 73.89%
13,040 $1.36 Million
Q3 2019

Nov 14, 2019
BUY
$86.25 - $120.16 $3.34 Million - $4.66 Million
38,757 Added 346.2%
49,952 $4.97 Million
Q2 2019

Aug 14, 2019
SELL
$107.38 - $129.34 $2.59 Million - $3.12 Million
-24,157 Reduced 68.33%
11,195 $1.28 Million
Q1 2019

May 14, 2019
SELL
$105.93 - $142.47 $1.17 Million - $1.58 Million
-11,056 Reduced 23.82%
35,352 $4.44 Million
Q4 2018

Feb 14, 2019
BUY
$128.36 - $272.13 $1.02 Million - $2.16 Million
7,921 Added 20.58%
46,408 $6.3 Million
Q3 2018

Nov 14, 2018
BUY
$211.18 - $274.49 $3.99 Million - $5.19 Million
18,899 Added 96.48%
38,487 $10.6 Million
Q2 2018

Aug 14, 2018
SELL
$150.77 - $207.98 $6.42 Million - $8.85 Million
-42,566 Reduced 68.48%
19,588 $4.06 Million
Q1 2018

May 15, 2018
BUY
$138.63 - $182.62 $7.09 Million - $9.34 Million
51,166 Added 465.65%
62,154 $10.3 Million
Q4 2017

Feb 14, 2018
SELL
$128.36 - $147.04 $2.08 Million - $2.38 Million
-16,213 Reduced 59.6%
10,988 $1.51 Million
Q3 2017

Nov 14, 2017
SELL
$120.91 - $137.94 $1.43 Million - $1.63 Million
-11,838 Reduced 30.32%
27,201 $3.7 Million
Q2 2017

Aug 14, 2017
BUY
N/A
20,258 Added 107.86%
39,039 $4.74 Million
Q1 2017

Nov 14, 2017
BUY
N/A
18,781
18,781 $1.99 Million

Others Institutions Holding LGND

# of Institutions
342
Shares Held
20.5M
Call Options Held
19K
Put Options Held
11.5K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $3.39B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email